Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

[European guidelines for lipid treatment are tailored according to risk level].

Wiklund O.

Lakartidningen. 2012 Sep 19-26;109(38):1653. Swedish. No abstract available.

PMID:
23094394
2.

[Mediterranean diet and statins against cardiovascular disease].

Håkansson J.

Lakartidningen. 2012 Sep 5-11;109(36):1540-3. Review. Swedish. No abstract available.

PMID:
23016236
3.

Are we lowering LDL cholesterol sufficiently?

Barter P, Rye KA.

Nat Clin Pract Cardiovasc Med. 2006 Jun;3(6):290-1. No abstract available.

PMID:
16728988
4.

Worth the wait? A new paradigm for treating cholesterol to reduce cardiovascular risk.

Messerschmidt K.

S D Med. 2014 Feb;67(2):70-1. No abstract available.

PMID:
24624603
5.

Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe.

Thompson GR, Catapano A, Saheb S, Atassi-Dumont M, Barbir M, Eriksson M, Paulweber B, Sijbrands E, Stalenhoef AF, Parhofer KG.

Curr Opin Lipidol. 2010 Dec;21(6):492-8. doi: 10.1097/MOL.0b013e3283402f53. Review.

PMID:
20935563
6.

Government cholesterol recommendations questioned.

Levenson D.

Rep Med Guidel Outcomes Res. 2004 Oct 15;15(20):9-10, 12. No abstract available.

PMID:
15505935
7.

[The discussion on target goals in lipid reduction is still going on. The Expert Committee--a block for current cardiovascular prevention].

Olsson AG.

Lakartidningen. 2011 Nov 23-29;108(47):2442-3. Swedish. No abstract available.

PMID:
22468387
8.

Aronow's "Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?" Commentary.

Mooradian AD.

J Gerontol A Biol Sci Med Sci. 2005 May;60(5):598; author reply 602. No abstract available.

PMID:
16094774
9.

Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?

Aronow WS.

J Gerontol A Biol Sci Med Sci. 2005 May;60(5):591-2. No abstract available.

PMID:
15972605
10.

[Treatment of dyslipidemia in 2014: European versus American guidelines].

Radermecker RP.

Rev Med Suisse. 2014 Aug 27;10(439):1534-7. French.

PMID:
25272669
11.

Heart health and diet.

Colt E.

J Am Diet Assoc. 2008 Jan;108(1):34. No abstract available.

PMID:
18155985
12.
13.

An update to the National Cholesterol Education Program: 2009 suggested changes.

Medina-Ruíz A.

Bol Asoc Med P R. 2009 Oct-Dec;101(4):30-3.

PMID:
20853557
14.

[Paradigm shift with the new American guidelines for lipid-lowering therapy].

Hjemdahl P, Andersén-Karlsson E.

Lakartidningen. 2014 Apr 2-8;111(14):596-7. Swedish. No abstract available.

PMID:
24779174
15.

Aronow's "Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?" Aim low.

Nash IS.

J Gerontol A Biol Sci Med Sci. 2005 May;60(5):599-600; author reply 602. No abstract available.

PMID:
15972609
16.

[2016 European Society of Cardiology guidelines for the management of dyslipidemias].

Ferrières J.

Presse Med. 2017 Jul - Aug;46(7-8 Pt 1):688-696. doi: 10.1016/j.lpm.2017.03.008. Epub 2017 May 10. French.

PMID:
28502376
17.

[Target levels for LDL cholesterol are put out of the running. Cholesterol should be lowered maximally in high cardiovascular risk].

Olsson AG.

Lakartidningen. 2011 Jun 1-14;108(22-23):1240-3. Review. Swedish. No abstract available.

PMID:
21786498
18.

[Guidelines for cholesterol treatment--the obstacle remains in Stockholm].

Olsson AG.

Lakartidningen. 2014 May 14-20;111(20):885. Swedish. No abstract available.

PMID:
24908807
19.

Counterpoint: Low-density lipoprotein cholesterol goals in patients with diabetes are adequately based on evidence.

Davidson MH.

J Clin Lipidol. 2010 Jan-Feb;4(1):72-3; discussion 74. doi: 10.1016/j.jacl.2010.01.001. Epub 2010 Jan 7. No abstract available.

PMID:
21122630
20.

Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.

Gotto AM Jr, Farmer JA.

Nat Clin Pract Cardiovasc Med. 2006 Dec;3(12):664-72. Review.

PMID:
17122799

Supplemental Content

Support Center